Scholar Rock Holding (STU:2QK) Long-Term Debt : €41.03 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Scholar Rock Holding Long-Term Debt?

Scholar Rock Holding's Long-Term Debt for the quarter that ended in Mar. 2024 was €41.03 Mil.

Scholar Rock Holding's quarterly Long-Term Debt declined from Sep. 2023 (€46.81 Mil) to Dec. 2023 (€44.64 Mil) and declined from Dec. 2023 (€44.64 Mil) to Mar. 2024 (€41.03 Mil).

Scholar Rock Holding's annual Long-Term Debt increased from Dec. 2021 (€42.85 Mil) to Dec. 2022 (€46.96 Mil) but then declined from Dec. 2022 (€46.96 Mil) to Dec. 2023 (€44.64 Mil).

Scholar Rock Holding Long-Term Debt Historical Data

The historical data trend for Scholar Rock Holding's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scholar Rock Holding Long-Term Debt Chart

Scholar Rock Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

20.29

42.85

46.96

44.64

Scholar Rock Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															46.54	46.06	46.81	44.64	41.03

Scholar Rock Holding (STU:2QK) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Scholar Rock Holding Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Scholar Rock Holding's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Scholar Rock Holding (STU:2QK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scholar Rock Holding Corp (STU:2QK) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SRRK:USA

Address

301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142

Website

https://www.scholarrock.com

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is Apitegroma which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGF?1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Scholar Rock Holding (STU:2QK) Headlines

No Headlines